Experiments are the lifeblood of R&D, but reagent failure drains important resources and impedes the advancement of quality candidates

of experimental failure
is due to reagents not working as intended**
$17.6 billion
is lost by life science companies
on this problem each year*†
Pipelines stall and
patients wait as drugs
get delayed

* Freedman, L., Cockburn, I. and Simcoe, T. (2015). The Economics of Reproducibility in Preclinical Research. PLOS Biology, 13(6), p.e1002165.

† Freedman et al. report figures for the US only. We have extrapolated their data to reflect the fact that the US accounts for 58% of global pharmaceutical R&D.
See https://www.abpi.org.uk/facts-and-figures/science-and-innovation/worldwide-pharmaceutical-company-rd-expenditure-by-country/.

BenchSci returns time to scientists and reduces unnecessary spend

We exponentially increase the speed and quality of life-saving research by empowering scientists with the world’s most advanced biomedical artificial intelligence to run more successful experiments.

Using machine learning, BenchSci puts the world’s biomedical knowledge at scientists' fingertips

1 - Curate
2 - Decode
3 - Present

Curate the world's largest collection of data from life science experiments and reagent catalogs


Decode and organize the information with reagent-specific machine learning models


Provide rapid insights in a clear, easy-to-use interface with turnkey deployment across an enterprise


The interface

BenchSci is the world leader in AI-Assisted Reagent Selection and experiment design

15 of the top 20 pharmaceutical companies in the world trust BenchSci, and it is used by over 31,000 scientists at 3,600 institutions worldwide


Companies using BenchSci save up to $6 million per year in hard costs alone**

** Based on proprietary customer spend analysis. Depends on a number of factors, including a company’s total annual reagent spend and its waste ratio.
If we had BenchSci we would have saved 3 months on our project
— Scientist at top 15 pharma company

Researchers using BenchSci move faster, with less time searching for and validating reagents

In partnership with the world's leading scientific publishers

spring nature 3
pnas 3
karger 3
wolters 3
wiley 3
aspet 3
asbmb 3
faseb 3
jama 1

Over 80% of scientists say that BenchSci accelerates their work^

^ On average from surveys conducted on hundreds of industry scientists across various therapeutic areas and geographies.

Proudly funded by F-Prime and Gradient Ventures, Google’s AI fund

Improve both the speed and quality of your R&D with BenchSci

Flask_Plexus 1 Industry
Get BenchSci’s AI-Assisted Reagent Selection for your enterprise
Learn More
Graduation_Plexus 1 Academics
Get access to BenchSci’s AI-Assisted Antibody Selection free
Sign Up